One of the most common questions patients ask after being diagnosed with early-stage lung cancer is indirectly linked to Segmentectomy vs Lobectomy, AND they frame it as:
“Do I need to lose an entire lobe of my lung, or can the surgeon remove only the cancerous part?”
For decades, the standard answer was straightforward: remove the entire lobe of the lung through a procedure called lobectomy. Since the landmark Lung Cancer Study Group trial in the 1990s, lobectomy has been regarded as the gold standard surgical treatment for early-stage non-small cell lung cancer (NSCLC).
However, advances in imaging, better lung cancer staging, minimally invasive thoracic surgery, and our understanding of lung cancer biology have led to renewed interest in segmentectomy, a lung-preserving procedure that removes only the diseased anatomical segment while preserving healthy lung tissue.
Recent landmark randomized controlled trials—including JCOG0802/WJOG4607L and CALGB 140503 (Alliance)—have demonstrated that, in carefully selected patients with small peripheral lung cancers, segmentectomy can provide oncological outcomes comparable to lobectomy while preserving more lung tissue. These studies have fundamentally changed how thoracic surgeons approach early-stage lung cancer.
Understanding the differences between segmentectomy and lobectomy is essential for patients making informed treatment decisions.
Understanding the Anatomy of the Lung
Before comparing the operations, it helps to understand lung anatomy.
The right lung consists of three lobes, while the left lung contains two lobes. Each lobe is further divided into smaller anatomical units called bronchopulmonary segments. Each segment has its own artery, vein, bronchus, and lymphatic drainage.
A lobectomy removes an entire lobe of the lung.
A segmentectomy removes only the specific segment or segments containing the cancer.
An easy way to understand this is to imagine a large apartment building.
- A lobectomy removes an entire floor.
- A segmentectomy removes only one apartment while preserving the rest of the floor.
This distinction is important because preserving healthy lung tissue may improve long-term respiratory function and quality of life, particularly in patients with smoking-related lung disease.
What Is a Lobectomy?
A lobectomy involves removal of the entire lung lobe containing the tumor, along with systematic lymph node assessment.
The procedure includes:
- Removal of the affected lobe
- Division of the pulmonary artery branches
- Division of pulmonary veins
- Division of the lobar bronchus
- Mediastinal and hilar lymph node dissection
Lobectomy can be performed through:
- Open thoracotomy
- Video-Assisted Thoracoscopic Surgery (VATS)
- Robotic-assisted thoracic surgery
The major advantage of lobectomy is that it provides a wide surgical margin and has a long history of excellent cancer control. Because of this extensive evidence base, lobectomy continues to be considered the standard surgical treatment for many patients with lung cancer.
What Is a Segmentectomy?
Segmentectomy is an anatomical lung-sparing procedure, based on the principles of bronchopulmonary segments.
Instead of removing an entire lobe, the surgeon removes only the segment containing the tumor while preserving the remainder of the lobe.
This operation requires:
- Identification of segmental arteries
- Identification of segmental veins
- Isolation of segmental bronchi
- Delineation of intersegmental planes
- Systematic lymph node evaluation
The objective is to completely remove the cancer while preserving as much normal lung tissue as possible.
Because the anatomy is considerably more complex than a lobectomy, segmentectomy is often regarded as one of the most technically demanding operations in thoracic surgery.
Segmentectomy vs Lobectomy: Key Differences
| Feature | Segmentectomy | Lobectomy |
| Amount of Lung Removed | Less | More |
| Preservation of Lung Function | Better | Less |
| Technical Complexity | Higher | Moderate |
| Surgical Margins | Smaller | Larger |
| Local Recurrence Risk | Slightly Higher | Slightly Lower |
| Suitability for Tumors ≤2 cm | Excellent | Excellent |
| Suitability for Tumors >2 cm | Select Cases | Preferred |
| Long-Term Evidence | Growing Rapidly | Extensive |
The key point is that these operations are not competitors.
They are different surgical tools designed for different clinical scenarios.
Who Is a Candidate for Segmentectomy?
Current evidence suggests that the best candidates for segmentectomy typically have:
- Peripheral lung cancers
- Tumors measuring 2 cm or less
- No lymph node involvement
- No distant metastases
- Adequate surgical margins achievable
These criteria are largely based on the patient populations enrolled in the JCOG0802 and CALGB140503 trials.
Segmentectomy may also be particularly valuable in patients with:
- COPD
- Emphysema
- Reduced pulmonary reserve
- Previous lung surgery
- Multiple lung nodules
Preserving lung tissue becomes increasingly important in these situations.
A comprehensive preoperative assessment should include:
- CT chest
- PET-CT scan
- Pulmonary function testing
- Cardiac evaluation when required
- Multidisciplinary tumor board discussion
Advantages of Segmentectomy
The primary advantage of segmentectomy is preservation of healthy lung tissue.
This can translate into:
- Better postoperative lung function
- Improved exercise capacity
- Greater respiratory reserve
- Better quality of life
- Potential for future lung surgery if needed
The JCOG0802 trial demonstrated superior overall survival for segmentectomy compared with lobectomy in carefully selected patients with peripheral tumors ≤2 cm. Five-year overall survival was approximately 94.3% after segmentectomy compared with 91.1% after lobectomy.
Several investigators believe this survival advantage may be partly related to preservation of lung function and a reduction in deaths from respiratory causes.
Advantages of Lobectomy
Despite growing enthusiasm for segmentectomy, lobectomy remains an excellent operation with important advantages.
These include:
- Wider surgical margins
- Lower local recurrence rates
- Greater applicability to larger tumors
- Extensive long-term evidence
While segmentectomy preserves lung tissue, some studies have reported higher local recurrence rates compared with lobectomy.
In JCOG0802, local recurrence occurred more frequently after segmentectomy despite superior overall survival.
For tumors measuring between 2 and 3 cm, several meta-analyses suggest that lobectomy may still provide superior oncological outcomes.
Therefore, lobectomy remains the preferred procedure for many patients with larger, central, or biologically aggressive tumors.
What Does the Latest Research Say about Segmentectomy vs Lobectomy ?
Two landmark trials have fundamentally changed the discussion.
JCOG0802/WJOG4607L Trial
Published in 2022, this Japanese phase III randomized trial enrolled more than 1,100 patients with peripheral NSCLC measuring 2 cm or less.
Key findings:
- Segmentectomy improved overall survival
- Better preservation of lung tissue
- Slightly higher local recurrence rates
The authors concluded that segmentectomy should be considered a standard treatment option for selected patients with small peripheral NSCLC.
CALGB 140503 (Alliance Trial)
Published in the New England Journal of Medicine in 2023, this multicenter international study compared lobectomy with sublobar resection (segmentectomy or wedge resection) for peripheral tumors ≤2 cm.
Key findings:
- Sublobar resection was non-inferior to lobectomy
- Similar disease-free survival
- Similar overall survival
This trial provided strong evidence supporting lung-preserving surgery in carefully selected patients.
Together, these studies have reshaped modern thoracic oncology.
Recovery After Surgery
Recovery depends more on the surgical approach than on whether a segmentectomy or lobectomy is performed.
Most modern lung cancer operations are performed using:
- VATS surgery
- Robotic surgery
Benefits include:
- Less postoperative pain
- Smaller incisions
- Shorter hospital stay
- Earlier mobilization
- Faster return to normal activities
Most patients can return to routine daily activities within several weeks following minimally invasive surgery.
Pulmonary rehabilitation and breathing exercises remain important components of recovery regardless of the operation performed.
Which Surgery Is Right for You? Segmentectomy vs Lobectomy
There is no universal answer.
The optimal operation depends on:
- Tumor size
- Tumor location
- PET scan findings
- Lymph node status
- Lung function
- Patient age
- Overall health
- Surgeon expertise
For example:
- A 1 cm peripheral adenocarcinoma may be ideally suited for segmentectomy.
- A 4 cm central tumor is generally better treated with lobectomy.
The decision should always be individualized and discussed with a dedicated thoracic surgeon.
Why Surgeon Experience Matters
Segmentectomy is among the most technically demanding procedures in thoracic surgery.
The operation requires expertise in:
- Complex segmental anatomy
- Minimally invasive techniques
- Lymph node staging
- Lung cancer biology
Successful outcomes depend heavily on appropriate patient selection, meticulous surgical technique, and adherence to oncological principles.
Not every surgeon performs advanced segmentectomies routinely, making specialized thoracic surgical experience particularly important. Dr Kamran Ali regularly performs Segmentectomies in his practice.
Segmentectomy vs Lobectomy: The Bottom Line
The question is no longer:
“Which operation is better?”
The real question is:
“Which operation is best for your specific cancer?”
Current evidence shows that for carefully selected patients with peripheral lung cancers measuring 2 cm or less, anatomical segmentectomy can provide survival outcomes comparable to—and in some studies better than—lobectomy while preserving more healthy lung tissue.
For larger tumors, central lesions, or cancers with suspected nodal involvement, lobectomy remains the preferred treatment.
Modern lung cancer surgery is increasingly personalized. The goal is simple:
Remove enough lung to cure the cancer, but no more than necessary.
Patients diagnosed with lung cancer should seek evaluation by an experienced thoracic surgeon who can discuss all available options and recommend the most appropriate operation based on their individual circumstances.
References
- JCOG0802/WJOG4607L Trial (Lancet, 2022)
https://pubmed.ncbi.nlm.nih.gov/35461558/ - CALGB 140503 Trial (NEJM, 2023)
https://www.nejm.org/doi/full/10.1056/NEJMoa2212083 - Review of JCOG0802 and CALGB140503
https://pmc.ncbi.nlm.nih.gov/articles/PMC11228729/ - AATS Commentary on CALGB140503
https://www.aats.org/resources/in-the-wake-of-calgb-140503-segmentectomy-vs-wedge-resection-for-early-stage-non-small-cell-lung-cancer - Meta-analysis of Segmentectomy vs Lobectomy
https://jtd.amegroups.org/article/view/77123/html
